Maury Marks, President and Chief Executive Officer and Marilyn Bown, Chief Financial Officer will present the Q4 and fiscal year 2024 Results at a conference call with concurrent audio webcast, ...

During Q4, the portfolio posted a negative total return but outperformed its benchmark (the Bloomberg U.S. Aggregate Index).

Q4 2024 revenue increased 12% YoY to $8.1 million Active users increased by 40% to 72,000 at the year-end 2024 Ontario market entry in progress with the launch of High Roller in H2, 2025 Las Vegas ...

BIO-key International, Inc. will host its Q4 2024 investor call on March 27th at 10 a.m. ET, with results expected to be released earlier that morning. CEO Mike DePasquale and CFO Cecilia Welch ...

Total Revenue (Q4 2024): $6.1 million, up 3% from $5.9 million in Q4 2023. Net Loss (Q4 2024): $1.2 million, improved from $1.9 million in Q4 2023. Gross Profit Margin (Q4 2024): Increased by 5 ...

The floor is yours. Good morning and welcome to SNDL's Q4 and full year 2024 financial and operational results conference call. 2024 has been a year of records for SNDL, and we are pleased to ...

an increase of about 10 percent compared to 58,559 units sold in Q4 2023. During the complete 2024 calendar year, Equinox sales decreased about 2 percent to 207,730 units. In Canada, Chevrolet ...

And now, regarding the investor relations calendar, Blink will be participating ... for non-cash items were reduced by 24% in 2024. Sequentially, our Q4 operating expenses were down 17% when ...

Greetings, and welcome to the Turtle Beach fourth quarter 2024 earnings conference call ... And the completion of our integration, activities in Q4 continued to drive results for the fourth ...

an increase of about 38 percent compared to 10,114 units sold in Q4 2023. During the complete 2024 calendar year, Express sales increased about 9 percent to 44,221 units. In Canada, Chevrolet ...

Here’s the updated list of Morningstar’s top underpriced analyst picks to buy during 2025’s second quarter. Maintaining independence and editorial freedom is essential to our mission of ...

Harvard Bioscience reported its Q4 2024 earnings, revealing an EPS of $0.06, surpassing the forecasted $0.05. Revenue also exceeded expectations, reaching $24.6 million compared to the anticipated $24 ...